The Kaplan‐Meier (K‐M) survival curve from the GEPIA database showed that low expression of SETD2 was associated with worse prognosis in ccRCC patients (Figure S2C, Supporting Information). The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.